Akute und chronisch entzündliche Neuropathien - Diagnostik[1]

Literatur

• 1 Asbury A K, Cornblath D R. Assessment of current diagnostic criteria for Guillain-Barre syndrome.  Ann Neurol. 1990;  27 S21-24 (Suppl)
• 2 Barohn R J, Kissel J T, Warmolts J R, Mendell J R. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria.  Arch Neurol. 1989;  46 878-884
• 3 Flachenecker P, Mullges W, Wermuth P, Hartung H P, Reiners K. Eyeball pressure testing in the evaluation of serious bradyarrhythmias in Guillain-Barre syndrome.  Neurology. 1996;  47 102-108
• 4 Flachenecker P, Toyka K V, Reiners K. Herzrhythmusstörungen beim Guillain-Barré-Syndrom. Eine Übersicht zur Diagnostik einer seltenen, aber potenziell lebensbedrohlichen Komplikation.  Nervenarzt. 2001;  72 610-617
• 5 Gordon P H, Wilbourn A J. Early electrodiagnostic findings in Guillain-Barre syndrome.  Arch Neurol. 2001;  58 913-917
• 6 Govoni V, Granieri E. Epidemiology of the Guillain-Barre syndrome.  Curr Opin Neurol. 2001;  14 605-613
• 7 Grand’Maison F, Feasby T E, Hahn A F, Koopman W J. Recurrent Guillain-Barre syndrome. Clinical and laboratory features.  Brain. 1992;  115 1093-1106
• 8 Green D M, Ropper A H. Mild Guillain-Barre syndrome.  Arch Neurol. 2001;  58 1098-1101
• 9 Hadden R D, Karch H, Hartung H P. et al . Preceding infections, immune factors, and outcome in Guillain-Barre syndrome.  Neurology. 2001;  56 758-765
• 10 Hahn A F. Guillain-Barre syndrome.  Lancet. 1998;  352 635-641
• 11 Hartung H P, Kieseier B C, Archelos J J. Neuromuskuläre Störungen beim Intensivpatienten. Berlin: Springer-Verlag In: Burchardi H, Larsen R., Schuster H. P., Suter P. M., eds. Intensivmedizin. 9. Auflage 2003
• 12 Hartung H P, Pollard J D, Harvey G K, Toyka K V. Immunopathogenesis and treatment of the Guillain-Barre syndrome-Part I.  Muscle Nerve. 1995;  18 137-153
• 13 Hartung H P, Willison H J, Kieseier B C. Acute immunoinflammatory neuropathy: update on Guillain-Barre syndrome.  Curr Opin Neurol. 2002;  15 571-577
• 14 Ho T W, McKhann G M, Griffin J W. Human autoimmune neuropathies.  Annu Rev Neurosci. 1998;  21 187-226
• 15 Hund E F, Borel C O, Cornblath D R, Hanley D F, McKhann G M. Intensive management and treatment of severe Guillain-Barre syndrome.  Crit Care Med. 1993;  21 433-446
• 16 Kieseier B C, Dalakas M C, Hartung H P. Immune mechanisms in chronic inflammatory demyelinating neuropathy.  Neurology. 2002;  59 S7-12
• 17 Kieseier B C, Hartung H P. Guillain-Barré Syndrome.  Adv Clin Neurosci. 2002;  12 317-341
• 18 Koga M, Yuki N, Hirata K. Antecedent symptoms in Guillain-Barre syndrome: an important indicator for clinical and serological subgroups.  Acta Neurol Scand. 2001;  103 278-287
• 19 Lawn N D, Fletcher D D, Henderson R D, Wolter T D, Wijdicks E F. Anticipating mechanical ventilation in Guillain-Barre syndrome.  Arch Neurol. 2001;  58 893-898
• 20 Lunn M P, Manji H, Choudhary P P, Hughes R A, Thomas P K. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England.  J Neurol Neurosurg Psychiatry. 1999;  66 677-680
• 21 Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) . Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force.  Neurology. 1991;  41 617-618
• 22 Ropper A H, Victor M. Influenza vaccination and the Guillain-Barre syndrome.  N Engl J Med. 1998;  339 1845-1846
• 23 Saperstein D S, Katz J S, Amato A A, Barohn R J. Clinical spectrum of chronic acquired demyelinating polyneuropathies.  Muscle Nerve. 2001;  24 311-324
• 24 Van der Meche F G, Van Doorn P A, Meulstee J, Jennekens F G. Diagnostic and classification criteria for the Guillain-Barre syndrome.  Eur Neurol. 2001;  45 133-139

1 Der Beitrag „Akute und chronisch entzündliche Neuropathien - Therapie“ erscheint im nächsten Heft (Nr. 25/26).